Live from the NIH registry
Studies recruiting near Modesto right now
Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Galleri® in the Medicare Population.
Cancer
N/A
Interventional 50,000 participants sought
Sutter Valley Hospitals Modesto — Modesto, California (0.3 mi)
· Sponsor: GRAIL, Inc.
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
Stockton Hematology Oncology Medical Group — Stockton, California (27.1 mi)
· Sponsor: Natera, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Paradigm Clinical Research - Modesto, CA /ID# 280611 — Modesto, California (0.3 mi)
· Sponsor: AbbVie
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Vancomycin Reduction Practices (VRP) in the NICU
Antibiotic Stewardship, Neonatal Sepsis, Late-Onset
N/A
Interventional 13 participants sought
Kaiser Permanente Modesto Medical Center — Modesto, California (0.3 mi)
· Sponsor: Children's Hospital of Philadelphia
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration, nAMD
Phase 3
Interventional 304 participants sought
Retinal Consultants Medical Group, Inc - Modesto (RCA) — Modesto, California (0.3 mi)
· Sponsor: Amgen
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: NRG Oncology
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Paradigm Clinical Research - Modesto — Modesto, California (0.3 mi)
· Sponsor: vTv Therapeutics
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Phase 2, Phase 3
Interventional 189 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
Bensch Clinical Research LLC — Stockton, California (27.1 mi)
· Sponsor: Biometry Inc
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: NRG Oncology
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: Canadian Cancer Trials Group
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor
Phase 2
Interventional 141 participants sought
Saint Joseph's Medical Center — Stockton, California (27.1 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
Memorial Medical Center — Modesto, California (0.3 mi)
· Sponsor: SWOG Cancer Research Network
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 626 participants sought
Stockton Hematology Oncology Medical Group (SHOMG) - Stockton (Suite B) — Stockton, California (27.1 mi)
· Sponsor: Mirati Therapeutics Inc.
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Kaiser Permanente- Modesto MOB II — Modesto, California (0.3 mi)
· Sponsor: National Cancer Institute (NCI)